Financials

  • Market Capitalization 375.39 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2
市销率
11.96

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3122
IPSC
Century Therapeutics, Inc. - Common Stock
2.11 USD-0.94%-11.72%-8.66%+263.79%380.55 M USD
3133
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
12.91 USD-1.53%-10.41%+12.85%+95.90%375.40 M USD
3142
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.70 USD0.00%-4.08%+6.82%+46.42%376.13 M USD
3174
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.62 USD0.00%-6.67%-2.12%+11.06%362.77 M USD

新闻